Fund Holdings — Alphabet Inc.

Total Portfolio Value
$2.14B
Total Bought
$2.59M
Total Sold
$116.74M
Net Transaction
-$114.15M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
AST SPACEMOBILE INC(ASTS)8,943,4868,943,4860203,375417,92919.57%+214,554
ARM HOLDINGS PLC1,960,7841,960,7840209,392317,13714.85%+107,745
PLANET LABS PBC(PL)31,942,64131,942,6410107,966194,8509.13%+86,884
VERVE THERAPEUTICS INC12,349,08612,168,489-180,59756,435136,6526.40%+80,217
TEMPUS AI INC(TEM)1,551,1021,551,102074,82598,5574.62%+23,732
DEXCOM INC(DXCM)1,036,9371,036,937070,81290,5144.24%+19,702
UIPATH INC(PATH)7,034,3377,034,337072,45490,0404.22%+17,586
FRESHWORKS INC(FRSH)16,206,64316,206,6430228,676241,64111.32%+12,965
PRIME MEDICINE INC(PRME)15,062,49815,062,498029,97437,2041.74%+7,230
METSERA INC4,961,7444,961,7440135,059141,1626.61%+6,103
REVOLUTION MEDICINES INC(RVMD)4,133,2774,133,2770146,153152,0637.12%+5,911
OSCAR HEALTH INC(OSCR)481,988481,98806,31910,3340.48%+4,015
MAZE THERAPEUTICS INC(MAZE)2,412,4712,412,471026,56129,6011.39%+3,040
SANA BIOTECHNOLOGY INC(SANA)2,812,5002,812,50004,7257,6780.36%+2,953
LYELL IMMUNOPHARMA INC(LYEL)0293,256+293,25602,5920.12%+2,592
SPERO THERAPEUTICS INC(SPRO)889,979889,97906412,5810.12%+1,940
RELAY THERAPEUTICS INC(RLAY)1,568,7531,568,75304,1105,4280.25%+1,318
TAYSHA GENE THERAPIES INC(TSHA)640,882640,88208911,4800.07%+590
FOGHORN THERAPEUTICS INC(FHTX)500,901500,90101,8282,3540.11%+526
AUTOLUS THERAPEUTICS PLC(AUTL)698,262698,26201,0821,5920.07%+510
FRACTYL HEALTH INC(GUTS)662,584662,58407881,0730.05%+285
EXACT SCIENCES CORP(EXK)23,20523,20501,0051,2330.06%+229
DIANTHUS THERAPEUTICS INC(DNTH)208,697208,69703,7863,8880.18%+102
GENEDX HOLDINGS CORP(WGS)22,71122,71102,0122,0960.10%+85
TSCAN THERAPEUTICS INC(TCRX)1,077,0801,077,08001,4861,5620.07%+75
QUINCE THERAPEUTICS INC(QNCX)189,122189,12202523120.01%+61
FULCRUM THERAPEUTICS INC(FULC)14,26214,262041980.00%+57
TENAYA THERAPEUTICS INC(TNYA)915,705915,70505225590.03%+37
ALECTOR INC175,866175,86602162460.01%+30
HYPERFINE INC(HYPR)898,720898,72006476470.03%0
REPLIGEN CORP(RGEN)383383049480.00%-1
BARINTHUS BIOTHERAPEUTICS PL(BRNS)1,513,6441,513,64401,4681,4080.07%-61
VERA THERAPEUTICS INC(VERA)241,264241,26405,7955,6840.27%-111
MONTE ROSA THERAPEUTICS INC(GLUE)1,464,0151,464,01506,7936,6030.31%-190
RANI THERAPEUTICS HLDGS INC(RANI)448,4920-448,4925650—-565
BEAM THERAPEUTICS INC(BEAM)321,604321,60406,2815,4700.26%-810
KRONOS BIO INC1,438,2320-1,438,2321,1940—-1,194
LYELL IMMUNOPHARMA INC(LYEL)5,865,1250-5,865,1253,1670—-3,167
GITLAB INC(GTLB)2,724,7122,724,7120128,061122,9125.76%-5,150
DESKTOP METAL INC1,104,8710-1,104,8715,4250—-5,425
CROWDSTRIKE HLDGS INC(CRWD)74,2300-74,23026,1720—-26,172
Page 1 of 1
Alphabet Inc. — 13F Holdings — Q2 2025 | TickerTrail